Exclusive Bionical EMAS speaker interview released for the Orphan Drugs & Rare Diseases Conference Read more
An exclusive speaker interview with twoXAR CEO for SMi’s 3rd Annual Ophthalmic Drugs Conference 2019 Read more
European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma Read more
Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409) Read more
Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of PNH Read more
ImmunoPrecise’s Talem Therapeutics Enters into an LOI with AgonOx Pharma in the Advancement of Novel, Immuno-Oncology Therapeutics Read more
Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia Read more
Aldeyra Therapeutics Receives Fast Track Designation for ADX-2191 for the Prevention of Proliferative Vitreoretinopathy Read more